Clinical Trial

Sensory and Cognitive Outcomes of Robotic Exercises in Stroke (SCORES)

Study acronym: SCORES
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
Based on the findings of meta-analyses, upper limb robotic rehabilitation has shown to enhance daily living activities, motor function, and strength in stroke patients. However, when compared to traditional methods, recent randomized controlled trials conducted on larger participant groups failed to identify significant differences in motor-related outcomes between the two approaches. In addition to motor deficits, stroke survivors often experience cognitive decline and sensory disturbances, which can significantly impede their recovery process. The introduction of multisensory stimulation and an enriched environment through robotic interventions may offer valuable supplementary treatments in these specific areas. Nevertheless, this aspect of treatment has not been thoroughly explored. This study seeks to assess the effectiveness of upper limb robotic rehabilitation in individuals recovering from subacute strokes, in comparison to conventional treatments. Specifically, it aims to determine whether this robotic therapy can lead to improvements in (a) cognitive deficits, (b) somatosensory impairment, and (c) how these sensory and cognitive deficits influence the process of motor recovery.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-30; most recent amendment 2024-10-10.
Status change: Not Yet Recruiting → Recruiting 2024-07-16
Trial Details
NCT Number NCT06109324
Lead Sponsor Fondazione Don Carlo Gnocchi ETS
Collaborators: IRCCS Centro Neurolesi Bonino Pulejo, Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
Conditions Stroke
Enrollment 126 participants
Start Date 2023-11-13
Primary Completion 2025-05 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-15